Saputo (TSE:SAP – Get Free Report) is set to issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of C$0.39 per share for the quarter. Saputo (TSE:SAP – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported […]

Veracyte (NASDAQ:VCYT – Get Free Report) is scheduled to release its earnings data after the market closes on Wednesday, November 6th. Analysts expect Veracyte to post earnings of $0.02 per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Veracyte (NASDAQ:VCYT – Get Free […]

Royalty Pharma (NASDAQ:RPRX – Get Free Report) will release its earnings data before the market opens on Wednesday, November 6th. Analysts expect Royalty Pharma to post earnings of $0.95 per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link. Royalty Pharma (NASDAQ:RPRX […]

ChromaDex (NASDAQ:CDXC – Free Report) had its price objective hoisted by HC Wainwright from $6.00 to $8.00 in a report released on Monday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for ChromaDex’s Q4 2024 earnings at $0.04 EPS, FY2024 earnings at $0.06 EPS, Q1 […]

Ramaco Resources (NASDAQ:METC – Get Free Report) issued its quarterly earnings data on Monday. The energy company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.01), RTT News reports. The business had revenue of $167.40 million for the quarter, compared to analyst estimates of $156.41 million. Ramaco […]

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) announced its earnings results on Monday. The specialty pharmaceutical company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.25, Briefing.com reports. Supernus Pharmaceuticals had a return on equity of 0.56% and a net margin of 0.83%. The business had revenue of […]

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) issued its earnings results on Monday. The specialty pharmaceutical company reported $0.69 earnings per share for the quarter, topping the consensus estimate of $0.44 by $0.25, Briefing.com reports. Supernus Pharmaceuticals had a return on equity of 0.56% and a net margin of 0.83%. The company had revenue of […]

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) posted its quarterly earnings results on Monday. The specialty pharmaceutical company reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.44 by $0.25, Briefing.com reports. Supernus Pharmaceuticals had a net margin of 0.83% and a return on equity of 0.56%. The business had […]

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) issued its quarterly earnings data on Monday. The specialty pharmaceutical company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.44 by $0.25, Briefing.com reports. The firm had revenue of $175.70 million during the quarter, compared to the consensus estimate of $157.35 million. […]

Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) will announce its earnings results after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of ($0.33) per share for the quarter. Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.40) […]

Aurora Cannabis (TSE:ACB – Get Free Report) is set to issue its quarterly earnings data before the market opens on Wednesday, November 6th. Analysts expect the company to announce earnings of C($0.14) per share for the quarter. Aurora Cannabis (TSE:ACB – Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The […]

AXT (NASDAQ:AXTI – Get Free Report) posted its quarterly earnings results on Thursday. The semiconductor company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.01), Zacks reports. AXT had a negative net margin of 14.75% and a negative return on equity of 5.87%. The company had revenue of $23.65 million […]

AXT (NASDAQ:AXTI – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of -0.050–0.030 for the period, compared to the consensus estimate of -0.040. The company issued revenue guidance of $23.0 million-$25.0 million, compared to the consensus revenue estimate of […]

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.87) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.51) by ($0.36), Zacks reports. The firm had revenue of $500.90 million for the quarter, compared to analyst estimates of $532.91 million. The company’s revenue […]

Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of $0.95 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link. Amphastar Pharmaceuticals (NASDAQ:AMPH […]

ChromaDex (NASDAQ:CDXC – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.02 earnings per share (EPS) for the quarter, Zacks reports. ChromaDex had a return on equity of 5.06% and a net margin of 1.62%. The business had revenue of $25.58 million during the quarter, compared to the consensus estimate […]

ChromaDex (NASDAQ:CDXC – Get Free Report) released its earnings results on Thursday. The company reported $0.02 earnings per share for the quarter, Zacks reports. ChromaDex had a return on equity of 5.06% and a net margin of 1.62%. The business had revenue of $25.58 million for the quarter, compared to analyst estimates of $23.70 million. […]

Federal Signal (NYSE:FSS – Get Free Report) announced its quarterly earnings results on Thursday. The conglomerate reported $0.88 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.04, Zacks reports. Federal Signal had a net margin of 11.57% and a return on equity of 18.46%. The firm had revenue of $474.20 […]

Fidus Investment (NASDAQ:FDUS – Get Free Report) released its quarterly earnings data on Thursday. The asset manager reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.57 by $0.04, Zacks reports. The company had revenue of $38.38 million during the quarter, compared to analysts’ expectations of $36.43 million. Fidus Investment had […]

OFS Capital (NASDAQ:OFS – Get Free Report) released its quarterly earnings data on Thursday. The investment management company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.25 by $0.02, Zacks reports. OFS Capital had a negative net margin of 2.29% and a positive return on equity of 11.19%. The business had revenue […]

Southern (NYSE:SO – Get Free Report) issued its quarterly earnings data on Thursday. The utilities provider reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.10, Zacks reports. Southern had a return on equity of 12.90% and a net margin of 17.87%. The firm had revenue of $7.27 billion […]

Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, November 5th. Analysts expect Syndax Pharmaceuticals to post earnings of ($1.13) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. Syndax Pharmaceuticals (NASDAQ:SNDX […]